Strikingly, in a prostate cancer focused study, suppressing RECQL4 to levels observed in non-malignant human epithelial cells is sufficient to reduce invasive growth and tumorigenic potential [38]. The gene discussed is RECQL4; the disease is prostate carcinoma.